Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.7K Sell
590
-177
-23% -$5.66K ﹤0.01% 803
2026
Q1
$12.6K Buy
767
+135
+21% +$2.14K ﹤0.01% 922
2025
Q4
$9.8K Hold
632
﹤0.01% 838
2025
Q3
$6.38K Buy
632
+127
+25% +$1.21K ﹤0.01% 769
2025
Q2
$4.81K Hold
505
﹤0.01% 752
2025
Q1
$3.49K Buy
505
+160
+46% +$1.53K ﹤0.01% 776
2024
Q4
$3.52K Hold
345
﹤0.01% 805
2024
Q3
$2.66K Hold
345
﹤0.01% 820
2024
Q2
$2.59K Buy
+345
New +$2.63K ﹤0.01% 824
2022
Q4
Sell
-220
Closed -$1K 820
2022
Q3
$1K Buy
+220
New +$1.69K ﹤0.01% 713

Other funds holding AIP

MCF Advisors's AIP Position: Q2 2026 in Review

MCF Advisors reduced its Arteris (AIP) stake by 23% in Q2 2026, selling an estimated $5.66K and leaving 590 shares worth $28.7K. The position accounts for ﹤0.01% of the portfolio, ranked #803.

MCF Advisors first reported a position in AIP in Q3 2022 and has held it in 10 quarters since. 211 funds tracked by Wall St. Rank hold AIP as of Q2 2026.

  • MCF Advisors held 590 shares of Arteris worth $28.7K as of Q2 2026.
  • MCF Advisors sold 177 Arteris shares in Q2 2026, an estimated $5.66K.
  • Arteris made up ﹤0.01% of MCF Advisors's portfolio in Q2 2026, its #803 holding.
  • MCF Advisors first reported a position in Arteris in Q3 2022 and has held it in 10 quarters since.
  • 211 funds tracked by Wall St. Rank held Arteris as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.